Should You Be Taking Probiotics for Crohn's Disease?

If you have Crohn’s disease, a form of inflammatory bowel disease (IBD), you may wonder if taking probiotic supplements could help manage your symptoms, or even help you reach or maintain remission.
Here’s how probiotics could potentially help, and what to look out for when deciding if you should take them.
Can Probiotics Help With Crohn’s Disease?
Probiotics are dietary supplements that contain potentially beneficial bacteria and sometimes other microorganisms, such as fungi.
It’s not exactly clear how helpful probiotics may be for Crohn’s disease, according to Berkeley Limketkai, MD, PhD, a gastroenterologist and director of clinical research at the UCLA Center for Inflammatory Bowel Diseases in Los Angeles.
“Unfortunately, probiotics have not been shown to be helpful for Crohn’s disease directly, for either induction of remission or maintenance of remission,” he says, in part due to a lack of robust studies. For that reason, Dr. Limketkai doesn’t typically recommend probiotics for his patients with Crohn’s.
Probiotics for Crohn’s vs. for Ulcerative Colitis
Compared with Crohn’s disease, there is greater evidence that taking probiotics may be helpful for ulcerative colitis (UC), a form of IBD that mainly affects the large intestine (colon) by causing ulcers to form.
Evidence of the Benefits of Probiotics for Crohn’s
After four weeks, participants who took the probiotic had better results in measures of inflammation and function of the gut mucosal barrier (cells that play a key role in absorbing nutrients).
The Benefits of Probiotics for Gut Health
Even though research hasn’t conclusively linked probiotics with remission in Crohn’s disease, that doesn’t mean they can’t be helpful for people with Crohn’s.
“Probiotics have been shown to be helpful for gut health in general,” says Limketkai, and Crohn’s can cause downstream digestive issues.
“When someone has Crohn’s disease, while inflammation is one factor that drives their symptoms, inflammation itself is an injury process,” he says. “And so it also then gives rise to other kinds of digestive issues” like irritable bowel syndrome (IBS), which probiotics may be able to improve.
The big takeaway, says Limketkai, is that if someone with Crohn’s is dealing with symptoms typical of a gut microbiome imbalance, it probably can’t hurt to try taking probiotics. “The risk profile is low,” he says. “It's generally helpful for the gut microbiome. That’s why it’s [sold] over the counter,” rather than by prescription. While there is a small risk of diarrhea, that’s true for anyone starting probiotics, not just people with Crohn’s, he says.
What to Know About Probiotic Supplements and Foods
If you’re considering taking a probiotic supplement, talk to your doctor first about the potential risks and benefits.
While your doctor may give you general guidance about choosing a supplement, there isn’t much evidence to recommend one product over another. “I'd love to be able to tell people, ‘Take X amount of Y strain and that should help your symptoms.’ Unfortunately, we're not there yet,” says Kelly Kennedy, RDN, a former staff nutritionist with Everyday Health.
Foods With Probiotics to Try
Alternatively, you can try incorporating natural probiotics into your diet by consuming foods like:
- Yogurt
- Kefir
- Cottage cheese
- Kombucha
- Kimchi
- Miso
- Sauerkraut
The Takeaway
- Some probiotic supplements may be beneficial for Crohn’s disease, but there is no strong evidence linking them to Crohn’s remission in most people.
- Certain bacterial strains in supplements may be more effective than others at relieving GI symptoms like abdominal pain, bloating, and straining.
- Both supplements and certain foods can provide beneficial probiotics, including yogurt, kefir, kombucha, and kimchi.
- Talk to your doctor if you’re unsure whether probiotic supplements may be right for you.
- Glassner KL et al. The Microbiome and Inflammatory Bowel Disease. Journal of Allergy and Clinical Immunology. January 2020.
- Limketkai BN et al. Probiotics for Induction of Remission in Crohn's Disease. Cochrane Library. July 17, 2020.
- Vakadaris G et al. The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature. Biomedicines. February 8, 2023.
- Shen M et al. Effects of Mesalamine Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules on Intestinal Mucosa Barrier Function and Intestinal Microbiota in Mildly Active Crohn’s Disease Patients. Journal of Investigative Surgery. December 30, 2023.
- Zhang T et al. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Frontiers in Cellular and Infection Microbiology. April 1, 2022.
- Goodoory VC et al. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Network Meta-analysis. Gastroenterology. November 2023.
- Cheng F-S et al. Probiotic Mixture VSL#3: An Overview of Basic and Clinical Studies in Chronic Diseases. World Journal of Clinical Cases. April 26, 2020.
- How to Get More Probiotics. Harvard Health Publishing. January 29, 2025.
- Probiotics. Cleveland Clinic. October 30, 2023.

Yuying Luo, MD
Medical Reviewer
Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York City. She aims to deliver evidence-based, patient-centered, and holistic care for her patients.
Her clinical and research focus includes patients with disorders of gut-brain interaction such as irritable bowel syndrome and functional dyspepsia; patients with lower gastrointestinal motility (constipation) disorders and defecatory and anorectal disorders (such as dyssynergic defecation); and women’s gastrointestinal health.
She graduated from Harvard with a bachelor's degree in molecular and cellular biology and received her MD from the NYU Grossman School of Medicine. She completed her residency in internal medicine at the Icahn School of Medicine at Mount Sinai, where she was also chief resident. She completed her gastroenterology fellowship at Mount Sinai Hospital and was also chief fellow.
